BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:TAK-781 readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of TAK-781\, from ClinicalTrials.gov estimat
 es.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07229911-11358@assetmemo.bio
DTSTAMP:20261121T005641Z
DTSTART;VALUE=DATE:20280406
DTEND;VALUE=DATE:20280407
SUMMARY:TAK-781: Phase 1 readout est. (NCT07229911)
DESCRIPTION:TAK-781\, phase 1\, Primary Sclerosing Cholangitis.\nStudy: A S
 tudy of TAK-781 in Healthy Volunteers and in Participants With Non-Cirrhot
 ic Primary Sclerosing Cholangitis (PSC)\nEstimated primary completion: 6 A
 pril 2028. This is a ClinicalTrials.gov estimate\, not a confirmed readout
  date\, and it can move.\nDrug page: https://assetmemo.bio/drug/tak-781#up
 coming-events\nRegistry record: https://clinicaltrials.gov/study/NCT072299
 11
URL:https://assetmemo.bio/drug/tak-781#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
